Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Daniel Sherbenou

Concepts (189)

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with Daniel Sherbenou's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Daniel Sherbenou has written about over time.
Piperazines, 5 publications between 2005 and 2010, average publication date October 2007. Pyrimidines, 5 publications between 2005 and 2010, average publication date October 2007. Fusion Proteins, bcr-abl, 4 publications between 2007 and 2010, average publication date April 2008. Leukemia, Myelogenous, Chronic, BCR-ABL Positive, 6 publications between 2005 and 2025, average publication date September 2010. Protein Kinase Inhibitors, 7 publications between 2005 and 2025, average publication date December 2011. Antineoplastic Agents, 5 publications between 2005 and 2024, average publication date March 2013. Drug Resistance, Neoplasm, 8 publications between 2005 and 2025, average publication date September 2013. Immunoconjugates, 3 publications between 2014 and 2020, average publication date June 2017. Antibodies, Monoclonal, 9 publications between 2014 and 2024, average publication date February 2020. Thalidomide, 3 publications between 2017 and 2024, average publication date June 2020. Multiple Myeloma, 18 publications between 2014 and 2025, average publication date September 2020. Antineoplastic Combined Chemotherapy Protocols, 7 publications between 2017 and 2025, average publication date January 2021. Hydrazines, 1 publications between 2021 and 2021, average publication date March 2021. Neoplasm Recurrence, Local, 4 publications between 2020 and 2024, average publication date May 2022. Interferon Regulatory Factors, 2 publications between 2020 and 2024, average publication date September 2022. Proto-Oncogene Proteins c-myc, 2 publications between 2020 and 2024, average publication date September 2022. Ikaros Transcription Factor, 1 publications between 2024 and 2024, average publication date July 2024. Immunoglobulin Light Chains, 1 publications between 2025 and 2025, average publication date January 2025. Osteolysis, 1 publications between 2025 and 2025, average publication date January 2025.

To see the data from this visualization as text, click here.
Sherbenou's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)